Response Evaluation in Neurofibromatosis and Schwannomatosis

REiNS is an international effort to develop new standardized response criteria for determining treatment response in patients with NF1, NF2, and schwannomatosis.  Response criteria will continue to be modified as we gain experience in clinical trials for NF.  We hope these criteria will be incorporated into future clinical trials and will improve our ability to determine and compare treatment efficacy.

For more information about this collaboration, please contact Dr. Scott R. Plotkin at